COVID-19 Lockdown Related Telemedicine for Type 2 Diabetes
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT04723550
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose health services research
- Phase
- Not applicable
- Enrolled
- 120 participants
- Sponsor
- Wenwen Yin
- Registry
-
NCT04723550
-
- Other papers using this trial's data
- Telemedicine management of type 2 diabetes mellitus in obese and overweight young and middle-aged patients during COVID-19 outbreak: A single-center, prospective, randomized control study
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04723550. Randomized; no masking; primary purpose health services research. Start 2021-01-05 (actual); primary completion 2021-11-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- COVID-19 Lockdown Related Telemedicine for Type 2 Diabetes
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Device)
- Hospital telemedicine management system
- Intervention (Other)
- Usual care
- Lead sponsor
- Wenwen Yin
Record details
- Record id
cardio:ct-nct04723550- Content hash
fee37493a355d8c151c03afbb4d0a52ce6cc6ab88dd3e013cca93e2e6956dae6